This article was originally published in The Tan Sheet
European Commission approves Pfizer's acquisition of Pharmacia pending divestiture of Netherlands-marketed antihypertensive drug, German-marketed animal antibiotic, which account for about $2.5 mil. in sales, Pfizer says Feb. 27. Firm now awaits FTC approval, still anticipates acquisition will close by the end of Q1 2003...
You may also be interested in...
A report from the US FDA says the agency will focus on updating its premarket submission portal, training staff and taking additional steps to start taking in applications for ASCA pilot participant sponsors.
With a late-stage compound on its hands, MGB is currently in discussions with several biotech and pharma companies and also with venture capitalists to continue late-stage development of a novel antibiotic which could transform treatment of Clostridium difficile.
AZ and the EU are at loggerheads over supplies of the COVID-19 vaccine. On top of that, its marketing authorization will present dilemmas.